Sensorion Stock OTC Markets
Stocks
SENOF
FR0012596468
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| Market Cap | 149M 172M 139M 127M 240M 16.37B 243M 1.63B 640M 8.2B 646M 632M 27.12B | P/E 2026 * |
-38.5x | P/E 2027 * | -6.42x |
|---|---|---|---|---|---|
| Enterprise Value | 16.75M 19.37M 15.65M 14.35M 27M 1.84B 27.42M 184M 72.05M 924M 72.73M 71.14M 3.05B | EV / Sales 2026 * |
0.77x | EV / Sales 2027 * | 23.3x |
| Free-Float |
70.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Frédéric Chéreau
CEO | Chief Executive Officer | 59 | 01/06/2026 |
Laurene Danon
DFI | Director of Finance/CFO | - | 26/06/2024 |
Bernd Schmidt
CTO | Chief Tech/Sci/R&D Officer | - | 11/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 09/03/2015 | |
Julien Miara
BRD | Director/Board Member | 43 | - |
Khalil Barrage
CHM | Chairman | 61 | 30/03/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 169M | |
| +0.99% | +1.78% | +4.07% | +16.73% | 48.7B | |
| +3.71% | +9.40% | +486.98% | +592.14% | 42.05B | |
| +2.70% | +1.57% | +33.39% | +8.85% | 38.26B | |
| +5.60% | +10.21% | +16.76% | +85.72% | 37.5B | |
| +2.21% | +6.75% | +21.31% | +53.37% | 31.44B | |
| +2.23% | +4.71% | - | - | 16.47B | |
| +0.97% | +2.35% | +37.75% | +126.84% | 16.33B | |
| -0.11% | +2.41% | +6.24% | +18.87% | 13.98B | |
| +0.75% | +15.04% | +78.59% | +30.30% | 12.68B | |
| Average | +1.90% | +5.63% | +85.64% | +116.60% | 28.6B | |
| Weighted average by Cap. | +2.51% | +5.04% | +103.57% | +139.73% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.86M 25.27M 20.41M 18.73M 35.22M 2.4B 35.78M 239M 94M 1.21B 94.89M 92.81M 3.99B | 6.4M 7.39M 5.97M 5.48M 10.3M 704M 10.47M 70.07M 27.5M 353M 27.76M 27.15M 1.17B |
| Net income | -237K -274K -221K -203K -381K -26.04M -387K -2.59M -1.02M -13.05M -1.03M -1M -43.15M | -36.12M -41.76M -33.73M -30.94M -58.2M -3.97B -59.12M -396M -155M -1.99B -157M -153M -6.59B |
| Net Debt | -132M -153M -123M -113M -213M -14.52B -216M -1.45B -568M -7.28B -573M -561M -24.07B | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALSEN Stock
- SENOF Stock
Select your edition
All financial news and data tailored to specific country editions
